Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae234 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Federico Barone und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Adenosine Monophosphate, Alanine, Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, Milan, Italy.
- III Infectious Diseases Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
- II Infectious Diseases Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
- Centre for Multidisciplinary Research in Health Science (MACH), Università degli Studi di Milano, Milan, Italy.
ORCID-Profile: Andrea Giacomelli, Alessia Lai, Spinello Antinori
Zitieren
APA
Barone, F., Giacomelli, A., Casalini, G., Corbellino, M., Lai, A., Gori, A., & Antinori, S. (2024). Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae234
Vancouver
Barone F, Giacomelli A, Casalini G, Corbellino M, Lai A, Gori A, et al. Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae234
BibTeX
@article{Barone2024,
author = {Barone, Federico and Giacomelli, Andrea and Casalini, Giacomo and Corbellino, Mario and Lai, Alessia and Gori, Andrea and Antinori, Spinello},
title = {Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae234}
}
EUVIMED